Evolution of Metastasis Study Models toward MetastasisOn-A-Chip: The Ultimate Model?
Metadatos
Afficher la notice complèteAuteur
Ruiz Espigares, Jesús; Jiménez, Gema; Marchal Corrales, Juan Antonio; Nieto, Daniel; Moroni, LorenzoEditorial
WILEY-V C H VERLAG GMBH
Date
2021Referencia bibliográfica
Ruiz‐Espigares, J., Nieto, D., Moroni, L., Jiménez, G., & Marchal, J. A. (2021). Evolution of Metastasis Study Models toward Metastasis‐On‐A‐Chip: The Ultimate Model?. Small. [DOI: 10.1002/smll.202006009]
Patrocinador
Ministerio de Educacion y Formacion Profesional FPU19/02138 BOE-B-2019-44783; Ph.D. program of Biomedicine of the University of Granada; Consejeria de Economia, Conocimiento, Empresas y Universidad, Junta de Andalucia (FEDER Funds) P18-FR-2470 B-CTS-230-UGR18 SOMM17/6109/UGR; Instituto de Salud Carlos III (FEDER Funds) PIE16-00045 DTS19/00145; Junta de Andalucia PIN-0224-2019; Chair "Doctors Galera-Requena in cancer stem cell research" CMC-CTS963Résumé
For decades, several attempts have been made to obtain a mimetic model for
the study of metastasis, the reason of most of deaths caused by cancer, in
order to solve the unknown phenomena surrounding this disease. To better
understand this cellular dissemination process, more realistic models are
needed that are capable of faithfully recreating the entire and essential tumor
microenvironment (TME). Thus, new tools known as tumor-on-a-chip and
metastasis-on-a-chip have been recently proposed. These tools incorporate
microfluidic systems and small culture chambers where TME can be faithfully
modeled thanks to 3D bioprinting. In this work, a literature review has been
developed about the different phases of metastasis, the remaining unknowns
and the use of new models to study this disease. The aim is to provide a
global vision of the current panorama and the great potential that these
systems have for in vitro translational research on the molecular basis of the
pathology. In addition, these models will allow progress toward a personalized medicine, generating chips from patient samples that mimic the original
tumor and the metastatic process to perform a precise pharmacological
screening by establishing the most appropriate treatment protocol.